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Abstract
Background: Malaria in pregnancy (MIP) has serious consequences for the woman, unborn child and newborn. The
use of sulfadoxine-pyrimethamine for the intermittent preventive treatment of malaria in pregnancy (SP-IPTp) is low
in malaria endemic areas, including some regions of Nigeria. However, little is known about pregnant women’s
compliance with the SP-IPTp national guidelines in primary health care (PHC) facilities in the south-south region
of Nigeria. The aim of this study was to identify the barriers to and determinants of the use of SP-IPTp among
pregnant women attending ANC in PHC facilities in Cross River State, south-south region of Nigeria.
Methods: A cross-sectional survey was conducted in 2011 among 400 ANC attendees aged 15–49 years recruited
through multistage sampling. Binary logistic regression was used to determine the factors associated with the use
of SP-IPTp in the study population.
Results: Use of SP-IPTp was self-reported by 41 % of the total respondents. Lack of autonomy in the households to
receive sulfadoxine-pyrimethamine (SP) during ANC was the main barrier to use of IPTp (83 %). Other barriers were
stock-outs of free SP (33 %) and poor supervision of SP ingestion by directly observed treatment among those who
obtained SP from ANC clinics (36/110 = 33 %). In the multivariate logistic regression, the odds of using SP-IPTp was
increased by the knowledge of the use of insecticide treated nets (ITNs) (OR = 2.13, 95 % CI: 1.70–3.73) and SP
(OR = 22.13, 95 % CI: 8.10–43.20) for the prevention of MIP. Use of ITNs also increased the odds of using SP-IPTp
(OR = 2.38, 95 % CI: 1.24–12.31).
Conclusions: Use of SP-IPTp was low and was associated with knowledge of the use of ITNs and SP as well as the
use of ITNs for the prevention of MIP. There is a need to strengthen PHC systems and address barriers to the usage
of SP-IPTp in order to reduce the burden of MIP.
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Background
Remarkable progress has been made in the global fight
against malaria. However, 3.4 billion people, including
pregnant women, are still at risk of malaria [1]. The
brunt of the global malaria burden is borne by sub-
Saharan Africa (SSA) [1, 2], where over 30 million
women become pregnant annually in malaria endemic
areas [2]. Pregnant women are the main adult group at
risk for malaria infection in endemic areas in SSA [2]. In
Nigeria, nearly 110 million cases of malaria are clinically
diagnosed per year. This makes malaria the most
common cause of hospital attendance in all age groups,
with estimated annual economic loses of over US$ 835
million from cost of treatment and absenteeism from
work and school [3–5]. It is estimated that malaria is
responsible for about 11 % of overall maternal mortality
in Nigeria [4, 5].
Malaria in pregnancy (MIP) can have serious health
consequences for the woman, unborn child and new-
born. The direct effect of MIP on the mother is severe
anaemia, resulting in an increased risk of maternal mor-
tality. The indirect consequences of MIP are twofold: (i)
intrauterine death/growth retardation of the foetus and
(ii) low birth weight in the newborn with consequent
higher risks of infant mortality and impaired child devel-
opment [2].
A three-prong approach is recommended for the control
of MIP in SSA: use of sulfadoxine-pyrimethamine for the
intermittent preventive treatment of malaria in pregnancy
(SP-IPTp), use of insecticide-treated bed nets (ITNs), and
effective case management of malarial illness [2].
About 90 % of pregnant women in Nigeria attend
some form of antenatal care (ANC) service [4]. This
offers an immense opportunity to encourage women to
utilise IPTp during ANC visits [4], particularly in
Primary Health Care (PHC) facilities, which are the
entry point into Nigeria’s health care system. In 2005,
the Federal Ministry of Health (FMOH) in Nigeria
adopted the IPTp as a part of focused ANC [6].
Provision of SP, at no cost to recipients, through Directly
Observed Treatment (DOT) supervised by a skilled
healthcare provider in public and faith based/NGO ante-
natal facilities is one of the strategies used to achieve the
target of 90 % of pregnant women receiving at least two
doses of sulfadoxine-pyrimethamine (SP) in the second
and third trimesters of pregnancy [4].
The current World Health Organization (WHO) IPTp
guidelines require that the first dose of SP-IPTp be given
as early as possible in the second trimester of gestation
with subsequent doses given at least one month apart.
The last dose can be administered up to the time of
delivery without safety concerns [7].
According to the 2009 Nigeria Health and Demographic
Survey (NHDS), 8 % of pregnant women reported the use
of one dose of SP-IPTp [8]. Studies have reported low use
of SP-IPTp in various regions of Nigeria [9–16] and SSA
[17]. Some of the perceived barriers to SP-IPTp use
include drug stock-outs in the health facilities, lack of
provider knowledge of the IPTp protocol, women’s belief
that SP is harmful to the foetus, and low levels of aware-
ness of the use of IPTp as a malaria preventive measure
[10, 15, 17, 18]. Various factors have been identified as
predictors of SP-IPTp use in PHC facilities in different re-
gions of Nigeria, all of which vary in seasonality, intensity
and duration of malaria transmission [19]. Knowledge of
prophylaxis for malaria prevention is associated with SP-
IPTp use in south-west Nigeria [20, 21], while advanced
maternal age, higher education, higher parity, lower
gestational age at registration for ANC, and use of ITNs
are associated with use of SP-IPTp in northern Nigeria
[14]. However, little is known about the determinants of
the use of free SP-IPTp in accordance with the national
treatment guidelines among women utilising ANC
services in PHC facilities in south-south Nigeria. The aim
of this research was to identify the barriers to and
determinants of the use of free SP-IPTp by pregnant
women attending ANC clinics in PHC facilities in Cross
River State, south-south Nigeria.
Methods
Study design and settings
We conducted a cross-sectional study to assess the use
of IPTp by pregnant women attending ANC clinics in
PHC facilities in Cross River State between September
and December 2011. The total population of the state is
2,892,988: males - 50.9 % (1,471,967) and females -
49.1 % (1,421,021) [22]. There are 18 Local Government
Areas (LGAs) in Cross River State. Of these, five, six and
seven LGAs constitute the northern, central and south-
ern senatorial or political districts that make up the
state, respectively. The state is situated in the tropical
rain forest belt of Nigeria where malaria transmission is
perennial [19].
Political and health structure
Nigeria is divided into six geo-political regions (north-east,
north-west, north-central, south-east, south-west and
south-south) to better enhance political administration of
the country by the Federal Government [23]. The season-
ality, intensity and duration of malaria transmission vary
across these geo-political regions of Nigeria with the
duration of malaria season being perennial in most of the
southern regions, but lasting three months or less in the
northern regions [19].
Three levels of health care delivery exist in Nigeria:
primary, secondary and tertiary. Local, State and Federal
Governments are responsible for primary, secondary and
tertiary health care, respectively [24]. The Local and
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State Government Ministries of Health are responsible
for coordinating health care delivery in 548 PHC
facilities and 17 secondary facilities in Cross River State
[19]. According to the national IPTp guidelines, health
care providers are expected to administer SP at no cost
to pregnant women attending ANC in public and faith-
based health facilities by directly observed treatment [4].
Sample size estimation
Using 8 % as the prevalence of SP-IPTp use at least once
during antenatal care [8], this study had a power of 80 %
to identify an odds ratio of 3 as significant at the 5 %
level [25, 26]. The minimum sample size of 400 pregnant
women was then calculated after accounting for 10 %
non-response.
Sampling technique
Multistage sampling was used to recruit 400 pregnant
women attending ANC in PHC facilities. In the first
stage, simple random sampling was used to select the
southern senatorial district from the three senatorial
districts in the state. In the second stage, Calabar south
and Odukpani LGAs were randomly selected from the
seven LGAs that constitute the southern senatorial
district. The third stage involved the random selection of
15 out of the 55 PHC facilities in the two LGAs. Finally,
the number of pregnant women recruited in each of the
15 PHC facilities was determined by proportionate
sampling using a sampling fraction of 400/1539, where
400 is the minimum sample size and 1539 is the total
number of pregnant women in the ANC rosters in the
15 PHC facilities (sampling frame) in August 2011, the
month before the study commenced. The sampling frac-
tion was multiplied by the number of patients in each
facility-specific roster to estimate the number of patients
per health facility (Additional file 1). Thereafter, preg-
nant women were recruited by systematic sampling until
the desired sample size in each clinic was achieved. The
sampling interval of 1 in 4 was used for the systematic
sampling in each facility with the starting point
determined by simple random sampling. The sampling
interval was derived by dividing the sampling frame
(1539) by the minimum sample size (400). Inclusion
criteria were the permanent residency status of the
prospective study participants in the community served
by the PHC facilities and having been registered in the
clinic roster.
Training and quality assurance
Data were collected using a semi-structured question-
naire that gathered information on socio-demographic
variables, obstetric characteristics, knowledge of malaria
and malaria prevention practices for the index preg-
nancy (Additional file 2). Fifteen field workers and five
supervisors were trained for three days on the adminis-
tration of the questionnaire. The questionnaire was pre-
tested in a PHC facility that was not on the list of study
sites in the main study. A debriefing session was held
after the pre-test to review challenges. Each field worker
was assigned to a PHC facility for data collection. Each
supervisor oversaw data collection in three PHC facilities.
The supervisors randomly checked completed ques-
tionnaires for errors and inconsistencies immediately
after the interviews. Questionnaires with errors were
immediately returned to the field worker for recon-
ciliation before data entry.
Variables
The outcome variable for the binary logistic regression
was the use of SP-IPTp in index pregnancy, with “yes”
or “no” responses coded as 1 or 0 respectively. A total of
12 independent variables were analysed in the bivariate
analysis. Among them were knowledge of bed nets, ITNs
and SP-IPTp as means of preventing MIP along with the
use of bed nets, and ITNs to prevent malaria in index
pregnancy. Other independent variables were obstetric
and socio-demographic characteristics of the respondents
such as women in their first pregnancy, number of
pregnancies, gestational age at registration for ANC in
index pregnancy, education, age, occupation and socio-
economic status. The socio-economic status (SES) of
respondents was constructed from 22 variables on house-
hold possessions and housing characteristics using the
principal components analysis (PCA) technique. [27] The
respondents’ total SES scores were categorised into
quintiles and labelled in ascending order: lowest; middle
low; middle; middle high; and highest.
Statistical analysis
Statistical analyses were conducted using STATA®
version 12. Mean values were calculated for continuous
variables while categorical variables were presented in
percentages. The cut-off point for the univariate logistic
regression (bivariate) analysis was set at 20 % signifi-
cance level. The relationship between each of the 12
independent variables and use of SP-IPTp was analysed
by forward selection in the bivariate analysis. Variables
that were not significantly (confidence intervals includ-
ing the null value of one) associated with use of SP-IPTp
in the bivariate analysis were excluded in the final
model. Interaction between independent variables was
tested. Variables that were significantly (confidence
intervals excluding the null value of one) associated with
the use of SP-IPTp in the bivariate analysis were
included in the multivariate logistic regression at 5 %
significance level. In order to minimise the chances of
underestimating the standard error, which arises from
clustered nature of data, we declared the data as survey
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data and used the “svyset” command in the regression
analysis. Estimates and standard errors were then
adjusted for the sampling design and weighted based on
the probability of a pregnant woman being selected.
Ethical clearance
Ethical approval for this study was obtained from the
Cross River State Research Ethics Committee. Permission
to conduct the study was received from the nurse-in-
charge of the selected PHC facilities. Field workers
described the study to the pregnant women and then
obtained written informed consent before enrolling the
women in the study.
Results
Socio-demographic and obstetric characteristics of the
respondents
Four hundred (400) pregnant women attending ANC in
the selected PHC facilities participated in the study.
Table 1 summarises the socio-demographic characteris-
tics of the respondents. The mean age of the women
was 25 ± 5.7 years, with nearly half (47 %) of the respon-
dents in the 15–24 year age category. Table 2 shows that
80 % of the women were in their second trimester at the
time of ANC registration.
Knowledge of malaria prevention practices in pregnancy
Table 3 shows that 62 % (248/400), 75 % (298/400) and
64 % (256/400) of women knew that mosquito bed nets,
ITNs and SP can be used to prevent MIP, respectively.
Of the 256 women who knew that SP are used for IPTp,
86 % knew the correct dose (number of pills) of SP to be
taken, whereas, only 38 % knew that SP should be taken
at the beginning of the second trimester.
Malaria prevention practices in index pregnancy
About 18 and 9 % of all the pregnant women, respect-
ively, reported the use of mosquito bed nets and ITNs
for malaria prevention during their index pregnancy.
Approximately 41 % (n = 165) and 1 % (n = 5) of all the
women, respectively, received one and two doses of
SP-IPTp during the study period. Other drugs report-
edly used for the prevention of malaria in the index
pregnancy were chloroquine® (6 %) and antibiotics
(2 %) - (Table 4).
Barriers to use of IPTp in index pregnancy
Table 5 shows that 83 % (n = 330) of the pregnant
women did not have the autonomy or freedom to re-
ceive SP-IPTp during ANC without consulting a house-
hold member. Of the 165 women who utilised IPTp,
67 % (n = 110) received SP from the ANC clinic while
33 % (n = 55) received SP from a drug vendor due to
drug stock-outs in the health facilities. Thirty-three
percent (n = 36) of the 110 women who obtained SP at
the ANC clinic ingested the SP by directly observed
treatment.
Determinants of the use of IPTp
In the multivariate binary regression analysis, the
women who were aware that ITNs are used to prevent
Table 1 Socio-demographic characteristics of the respondents
attending ANC in Cross River State
Variable n (%) (95 % CI)
Age (years)
15–24 187 (46.8) (42.8–51.8)
25–34 183 (45.7) (40.8–50.8)
35–49 30 (7.5) (5.1–10.5)
Mean (SD) (95 % CI) 25.2 (5.7) (24.7–25.8)
Education
None 28 (7.0) (4.7–10.0)
Primary 87 (21.7) (17.8–26.1)
Secondary 226 (56.5) (51.5–61.4)
Tertiary 59 (14.8) (11.4–18.6)
Religion
Christianity 399 (99.7) (98.6–99.9)
Islam 1 (0.3) (0.1–1.4)
Marital status
Single 79 (19.7) (16.0–24.0)
Married 310 (77.5) (73.1–81.5)
Othersa 11 (2.8) (1.4–4.9)
Ethnicity
Efik 119 (29.8) (25.3–34.5)
Ibibio 145 (36.2) (31.5–41.2)
Anang 83 (20.8) (16.9–25.1)
Othersb 53 (13.2) (10.1–17.0)
Occupation
None 78 (19.5) (15.3–23.7)
Farming 53 (13.2) (10.1–17.0)
Trading 158 (39.5) (34.7–44.5)
Fishing 8 (2.0) (0.9–3.9)
Civil service 66 (16.5) (13.0–20.5)
Othersc 37 (9.3) (6.6–12.5 )
Socio-economic status
Lowest 67 (16.8) (13.7–20.1)
Middle low 91 (22.7) (19.3–26.5)
Middle 82 (20.5) (17.2–24.1)
Middle high 80 (20.0) (16.8–23.6)
Highest 80 (20.0) (16.8–23.6)
aOthers included divorced, separated and widowed
bOthers included other ethnic groups other than Efik, Ibiobio and Anang
cOthers included students and artisans
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MIP had twofold increased odds (OR = 2.13, 95 % CI:
1.70–3.73) of using SP-IPTp compared with those with
no knowledge of ITNs. Similarly, the women who knew
that SP is used to prevent MIP had 22 fold increased
odds (OR = 22.13, 95 % CI: 8.10–43.20) of using IPTp
compared with those with no knowledge of SP. Pregnant
women who used ITNs to prevent MIP had twofold in-
creased odds (OR = 2.38, 95 % CI: 1.24–12.31) of using
SP-IPTp than those who did not use ITNs (Table 6).
Discussion
The aim of this study was to identify the barriers to and
determinants of the use of SP-IPTp by pregnant women
attending ANC clinics in PHC facilities in Cross River
State, south-south Nigeria. We observed high knowledge
Table 2 Obstetric characteristics of the respondents attending
ANC in Cross River State
Variable n (%) (95 % CI)
Gestational age at registration for ANC (months)
1–3 (First trimester) 32 (8.0) (5.5–11.1)
4–6 (Second trimester) 319 (79.8) (75.5–83.6)
7–9 (Third trimester) 49 (12.2) (9.2–15.9)
Mean gestational age (SD) (95 % CI) 5 (1.2) (4.9–5.1)
Gestational age at time of interview (months)
4–6 (Second trimester) 249 (62.2) (57.3–67.1)
7–9 (Third trimester) 151 (37.8) (33.0–42.7)
Mean gestational age (SD) (95 % CI) 6 (1.3) (5.9–6.3)
Total number of pregnancies
1(Primigravid women) 166 (41.5) (36.6–46.5)
2–4 178 (44.5) (39.6–49.5)
≥ 5 56 (14.0) (10.8–17.8)
Total number of children
0 (Primigravid women) 166 (41.5) (36.6–46.5)
1–4 221 (55.2) (50.2–60.1)
≥ 5 13 (3.3) (1.7–5.5)
Total number of miscarriages (n–234)
0 158 (67.5) (61.1–73.5)
1 64 (27.4) (21.7–33.5)
2 12 (5.1) (2.7–8.8)
Table 3 Knowledge of malaria prevention in pregnancy among
respondents attending ANC in Cross River State
Variable n (%) (95 % CI)
Mosquito bed nets
Yes 248 (62.0) (57.0–66.8)
No 152 (38.0) (33.2–43.0)
Insecticide-treated mosquito bed nets
Yes 298 (74.5) (70.0–78.7)
No 102 (25.5) (21.3–30.1)
SP
Yes 256 (64.0) (59.1–68.7)
No 144 (36.0) (31.3–40.9)
Correct dose of SP (n = 256)
Yes 220 (85.9) (81.1–90.0)
No 36 (14.1) (10.1–18.9)
Gestational age for taking SP (n = 256)
First trimester 44 (17.2) (12.8–22.4)
Second trimester 97 (37.9) (31.9–44.1)
Third trimester 22 (8.6) (5.5–12.7)
Don’t know 93 (36.3) (30.4–42.5)
Table 4 Malaria prevention practices in index pregnancy
among respondents attending ANC in Cross River State
Variable n (%) (95 % CI)
Use of mosquito bed nets
Yes 70 (17.5) (13.9–21.6)
No 330 (82.5) (78.4–86.1)
Use of ITNs
Yes 34 (8.5) (6.0–11.7)
No 366 (91.5) (88.3–94.0)
Use of SP
Yes 165 (41.2) (36.4–46.2)
No 235 (58.8) (53.8–63.6)
Doses of SP received (n = 400)
One 165 (41.2) (36.4–46.2)
Two 5 (1.3) (0.4–2.9)
Use of other drugs for preventing MIP
Chloroquine® 25 (6.3) (4.1–9.1)
Antibiotics 8 (2.0) (0.9–3.9)
Table 5 Barriers to SP-IPTp use among respondents attending
ANC in Cross River State
Variable n (%) (95 % CI)
Lack of autonomy of decision-making (n = 400)
Yes 330 (82.5) (78.4–86.1)
No 70 (17.5) (13.9–21.6)
Source of SP among those who used it (n = 165)
ANC clinic 110 (66.7) (58.9–73.8)
Drug vendor 55 (33.3) (26.2–41.1)
Reason for buying SP from a drug vendor (n = 55)
Stock-out of SP in the ANC clinic 55 (100) (0.94–1.00)
Directly observed treatment during ANC visit (n= 110)
Yes 36 (32.7) (24.1–42.3)
No 74 (67.3) (57.7–75.9)
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Table 6 Determinants of IPTp use among pregnant women attending ANC in Cross River State
Variable Use of SP for the intermittent preventive treatment of malaria (N = 400)
Yes No Unadjusted OR Adjusted OR
n (%) n (%) (80 % CI) (95 % CI)
165 (41.2) 235 (58.8)
Age group (years)
15–24 69 (41.8) 118 (50.2) 1 a
25–34 81 (49.1) 102 (43.4) 1.36 (0.52–3.56)
35–49 15 (9.1) 15 (6.4) 1.71 (0.37–7.88)
Education
None 7 (4.2) 21 (8.9) 1 1
Primary 31 (18.8) 56 (23.8) 1.66 (1.00–2.74) 1.72 (0.05–65.40)
Secondary 97 (58.8) 129 (54.9) 2.26 (0.62–8.22) 1.20 (0.02–61.50)
Tertiary 30 (18.2) 29 (12.4) 3.10 (2.11–4.57) 1.55 (0.03–82.20)
Occupation
None 16 (9.7) 62 (26.4) 1 1
Civil service 37 (22.4) 29 (12.3) 0.40 (0.08–1.98) 0.75 (0.01–11.87)
Farming 18 (10.9) 35 (14.9) 0.78 (0.24–2.59) 2.72 (0.73–10.23)
Fishing 4 (2.4) 4 (1.7) 0.20 (0.04–1.17) 0.29 (0.06–13.46)
Trading 76 (46.1) 82 (34.9) 0.48 (0.07–3.42) 0.57 (0.01–16.73)
Other 14 (8.5) 23 (9.8) 0.73 (0.59–0.89) 0.88 (0.26–2.99)
Socio-economic status
Lowest 29 (17.6) 38 (16.2) 1 1
Middle low 43 (26.1) 48 (20.4) 1.91 (1.21–3.01) 2.19 (0.06–78.02)
Middle 33 (20.0) 49 (20.9) 1.57 (0.94–2.63) 0.99 (0.10–9.91)
Middle high 36 (21.8) 44 (18.7) 2.09 (2.05–2.13) 2.82 (0.19–42.87)
Highest 24 (14.5) 56 (23.8) 1.78 (1.42–2.24) 1.24 (0.04–35.81)
First pregnancy
No 104 (63.0) 130 (55.3) 1 a
Yes 61 (37.0) 105 (44.7) 0.73 (0.32–1.65)
Number of pregnancies
1 61 (37.0) 105 (44.7) 1 a
2–4 79 (47.9) 99 (42.1) 1.37 (0.61–3.08)
≥ 5 25 (15.1) 31 (13.2) 1.39 (0.58–3.32)
Gestational age at registration for ANC
First trimester 16 (9.7) 16 (6.8) 1 a
Second trimester 132 (80.0) 187 (79.6) 0.71 (0.27–1.86)
Third trimester 17 (10.3) 32 (13.6) 0.53 (0.21–1.37)
Knowledge of bed nets
No 101 (61.2) 147 (62.6) 1 a
Yes 64 (38.8) 88 (37.4) 1.06 (0.45–2.48)
Knowledge of ITNs
No 26 (15.8) 76 (32.3) 1 1
Yes 139 (84.2) 159 (67.7) 2.56 (2.28–2.87) 2.13 (1.70–3.73)
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of the use of mosquito bed nets, ITNs and SP as means
of preventing MIP. However, the actual use of these
measures to prevent MIP was low. Based on the find-
ings, we noted that the lack of autonomy or freedom to
receive SP-IPTp during ANC without consulting a
household member, stock-outs of free SP, and poor
implementation of directly observed treatment in the
ANC clinics were potential critical barriers to the use of
IPTp. Knowledge and practices related to the prevention
of MIP were associated with use of IPTp in the index
pregnancy.
Our research findings corroborate results from similar
studies conducted in PHC facilities in south-west [10, 20]
and northern [14] Nigeria which showed high levels of
awareness of ITNs and SP as important predictors of
MIP-related preventive behaviour. The reported high
knowledge of ITNs and SP as malaria preventive measures
in pregnancy may be attributed to health education
received during ANC, which is widely utilised by pregnant
women in Nigeria [4]. The possible effects of ANC
attendance on increasing awareness of malaria preventive
measures in pregnancy are further corroborated by a
study in Burkina Faso which showed that non-ANC users
were significantly less knowledgeable about malaria/an-
aemia prevention measures than ANC users [28]. How-
ever, we also recognise that the knowledge gap between
ANC and non-ANC users can reflect higher educational
levels among women who use ANC relative to those who
do not [28].
Late ANC attendance (reflected by late gestational age
at registration for ANC) and poor knowledge of the
gestational age for taking SP have been identified as
individual barriers to the use of SP-IPTp in our study.
As previously reported in Gambia [29], poor knowledge
of the correct timing of ingestion of SP was associated
with low use of SP-IPTp. This may have serious health
implications particularly in a context where women are
likely to purchase SP from service providers in the infor-
mal health sector (e.g. drug stores), some of whom may
be inadequately informed about the appropriate
gestational age for the ingestion of SP. As such, health
education programmes targeting pregnant women and
drug vendors may be needed. This is in view of the
literature evidence showing that informal health care
providers such as drug vendors, traditional birth atten-
dants and adolescent peer mobilisers are capable of
increasing access to and compliance with SP-IPTp [30].
The lack of autonomy or freedom to receive SP-IPTp
during ANC without consultations with a family mem-
ber, notably the head of the household, is a household
barrier to the use of SP-IPTp in this study. Refusal to
receive SP during ANC visits may be due to perceived
adverse effects of SP on pregnancy as previously
reported in Cross River State [15] and south-west
Nigeria [10, 18]. Iliyasu et al. reported a similar finding
in northern Nigeria, but attributed cultural factors as the
reasons for refusal of pregnant women to use SP without
prior consent from their husbands [14].
Institutional barriers to the use of SP-IPTp in this
study were stock-outs of free SP due to sporadic
availability of SPs in health facilities [31] and poor
compliance with DOT. In assessing compliance with
Nigeria’s IPTp guidelines, approximately one-third of the
pregnant women who used SP-IPTp in this study were
directly observed ingesting SP by a health worker. Poor
compliance with national preventative treatment guide-
lines has been reported elsewhere in northern [14] and
south-west [10, 18] Nigeria. The reasons for poor imple-
mentation of DOT in these previous studies included: (i)
the practice in which pregnant women received SP from
ANC clinic, but took them home in order to have a meal
before taking the medicine, and (ii) procurement of SP
from drug vendors, often due to drug stock-outs in the
health facilities [3, 10, 14, 21]. Poor compliance with the
national guidelines underscores the need to assess and
enhance the capacity of PHC facilities in Nigeria to
implement the DOT strategy as well as to ensure the
availability of free SP in health facilities.
Table 6 Determinants of IPTp use among pregnant women attending ANC in Cross River State (Continued)
Knowledge of SP-IPTp
No 9 (5.4) 135 (57.5) 1 1
Yes 156 (94.6) 100 (42.5) 23.4 (5.1–47.3) 22.13 (8.10–43.20)
Use of bed nets
No 133 (80.6) 197 (83.8) 1 a
Yes 32 (19.4) 38 (16.2) 1.25 (0.79–1.96)
Use of ITNs
No 144 (87.3) 222 (94.5) 1 1
Yes 21 (12.7) 13 (5.5) 2.49 (1.83–3.39) 2.38 (1.24–12.31)
aNot included in the final model due to non-significance in the univariate model
Odds ratio were adjusted in the multivariate model for education, occupation, socio-economic status, knowledge of ITNs, knowledge of SP-IPTp and use of ITNs
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The 41 % prevalence of the use of one dose of SP-
IPTp in this study is similar to the 40 % prevalence
described by Amoran et al. [21]. The 41 % preva-
lence reported in our study shows an improvement
over the 8 % prevalence previously reported in the
2009 NHDS [8] and 27 % prevalence described by
Akinleye et al. [10] in south-west Nigeria. In Cross
River State, Esu et al. reported higher (53 %) usage
of one dose of SP-IPTp than the 41 % reported in
this study [16]. The higher rate reported by Esu et
al. can be attributed to the fact that their study was
conducted in both primary and secondary health fa-
cilities with the latter recording higher ANC attend-
ance due to the provision of ANC services therein by
medical doctors. A plethora of literature showed
undercoverage of SP-IPTp in Nigeria [9–16] com-
pared with the Role Back Malaria (RBM) 80 % cover-
age target in 2010 [32]. Reception of the
recommended minimum of two doses of SP-IPTp
was very low in this study because the study partici-
pants were not followed-up till delivery due to the
cross-sectional design of this study.
Knowledge of ITNs and SP as means of preventing
MIP was associated with the use of SP-IPTp in this
study. A similar finding was also reported in south-
west Nigeria [21] and some in some sub-Saharan
African countries [17]. A meta-analysis of factors
affecting the use of interventions to prevent MIP
showed that women who knew the benefits of SP-
IPTp, and how and when to take SP were more likely
to use SP-IPTp [17]. Use of ITN also determined the
use of SP-IPTp, as was reported by Iliyasu et al. in
northern Nigeria [14]. It is expected that mothers
who use ITNs are more likely to be exposed to health
education programmes focusing on the consequences
of MIP and are, therefore, more willing to use SP-
IPTp [14]. Similar to the findings reported by
Akinyele et al. in south-west Nigeria [10], there was
no significant relationship between maternal age,
gestational age at registration for ANC and the use of
SP-IPTp in our study.
Our study findings should be interpreted in light of
the following limitations: self-reported use SP-IPTp by
the women and our inability to follow-up with the
women till delivery to estimate compliance with the
recommended total dose of SP-IPTp according to the
national guidelines. We were unable to collect facility-
level data on other barriers to the use of SP-IPTp in the
PHC facilities.
Conclusions
Our study findings underscore the importance of
assessing and addressing individual, household and
facility factors that may impede the use of SP-IPTp. In
particular, levels of awareness and non-compliance of
PHC facilities to treatment guidelines may hamper
efforts to reduce maternal and child morbidity and
mortality associated with malaria. Health education
programmes on the prevention of malaria are needed.
These programmes should target mothers, heads of
households and a wide range of health providers. In
addition, programmes are needed to enhance the
capacity of PHC facilities to implement the SP-IPTp
guidelines.
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